Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Post by Mbxwatcheron Apr 29, 2021 2:36pm
279 Views
Post# 33094754

Legitimate questions

Legitimate questionsI enjoy this board and read it everyday.
I dont have much to contribute at this time, but will say i am dissappointed with the timing of the financing.   Overall it is a fair deal, and if it is in fact applied to significant growth, I may come to love it at some point.

My only point in posting today, is to say that I believe all the inquiries on this board are legitimate.
It is fair to wonder why the financing is so much and why now, given that the press release really gives very little explanation as to the size of it.
It is also fair to point out that there are alot of outstanding warrants that are in the money and wonder why that revenue cannot be tapped as opposed to further dilution.
It was fair to ask why the Plexxus deal took so long.  

Cameron and the current management team have done a great job, and I look forward to owning shares here for a long time.     I think that asking questions is a good thing, and we should keep doing it.     As well as some of the great posts, that are made here about how much VTM we import, and how big that market is, the questions as to why the financing was done now and to these levels are legitimate.   Hopefully we get some more commentary on that in the near future

<< Previous
Bullboard Posts
Next >>